Brief: Karyopharm Announces Significant Refinancing Transactions

Karyopharm Therapeutics

08/05/2024 14:07

May 8 (Reuters) - Karyopharm Therapeutics Inc  KPTI.O :
    * KARYOPHARM ANNOUNCES SIGNIFICANT REFINANCING TRANSACTIONS
AND
AMENDED ROYALTY AGREEMENT EXTENDING VAST MAJORITY OF ITS DEBT
MATURITIES INTO 2028 AND 2029
    * KARYOPHARM THERAPEUTICS INC - ISSUES NEW $100.0 MILLION
SENIOR
SECURED TERM LOAN DUE IN 2028
    * KARYOPHARM REFINANCES DEBT; MATURITIES EXTENDED TO
2028/2029
    * KARYOPHARM THERAPEUTICS- $148 MILLION OF EXISTING
CONVERTIBLE
NOTES DUE IN 2025 TO BE EXCHANGED FOR $111 MILLION OF NEW
CONVERTIBLE NOTES DUE IN 2029,WARRANTS

Source text for Eikon:  ID:nPn1X7C51a 
Further company coverage:  KPTI.O 

 ((Reuters.Briefs@thomsonreuters.com;))